Almanack Investment Partners’s GSK GSK Stock Holding History

Almanack Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,539	Closed	-$239K	–	188
2025 Q3	$239K	Buy	+5,539	New	+$216K	0.04%	174
2022 Q4	–	Sell	-9,280	Closed	-$273K	–	586
2022 Q3	$273K	Buy	9,280 +3,800	+69%	+$144K	0.05%	116
2022 Q2	$301K	Hold	5,480	–	–	0.03%	317
2022 Q1	$303K	Hold	5,480	–	–	0.03%	361
2021 Q4	$306K	Buy	+5,480	New	+$285K	0.02%	366
2020 Q4	–	Sell	-10,807	Closed	-$267K	–	421
2020 Q3	$267K	Buy	+10,807	New	+$541K	0.03%	317

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return

Holocene Advisors

Holocene Advisors New York $41.3B AUM 42.97% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return